[HTML][HTML] What are the current approaches to optimising antimicrobial dosing in the intensive care unit?
Antimicrobial dosing in the intensive care unit (ICU) can be problematic due to various
challenges including unique physiological changes observed in critically ill patients and the …
challenges including unique physiological changes observed in critically ill patients and the …
Meropenem–nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection model
TE Asempa, A Motos, K Abdelraouf, C Bissantz… - International journal of …, 2020 - Elsevier
Nacubactam is a novel non-β-lactam diazabicyclooctane β-lactamase inhibitor under
development for the treatment of serious Gram-negative infections. This study assessed the …
development for the treatment of serious Gram-negative infections. This study assessed the …
External evaluation of population pharmacokinetic models for continuous administration of meropenem in critically ill adult patients
Abstract Purpose Beta-lactams (BL), the most commonly prescribed class of antibiotics, are
recommended as the first-line therapy for multiple indications in infectious disease …
recommended as the first-line therapy for multiple indications in infectious disease …
[PDF][PDF] Corrigendum to “Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study …
SAM Dhaese, ADJ Thooft, A Farkas, J Lipman… - Journal of Critical …, 2020 - academia.edu
The authors regret that in the manuscript under section 2.3 Definition of target attainment the
following is written:“Based on this data, an unbound TZP concentration of 160 mg/L and an …
following is written:“Based on this data, an unbound TZP concentration of 160 mg/L and an …